Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 Jan;15(1):104–108. doi: 10.1128/iai.15.1.104-108.1977

Homologous and heterologous protection of mice with group A streptococcal M protein vaccines.

M K Wittner, E N Fox
PMCID: PMC421334  PMID: 319054

Abstract

Purified streptococcal M proteins precipitated with alum (APM) were used to immunize mice. A trivalent vaccine of serotypes 1, 3, and 12 protected mice against challenges by homologous live streptococci and also conferred protection against serotypes 6 and 14 but not against a strain of group B streptococci. Monovalent APM vaccines afforded homologous protection and restricted heterologous protection. The extent of heterologous protection was a function of serotype combinations and was also dose dependent. Rabbit antisera exhibiting strong opsonic activities were active in vitro and in passive mouse protection only for homologous serotypes. Mouse antisera did not passively transfer protection and were not bactericidal in vitro. It was concluded that homologous and heterologous active mouse protection was most likely a result of shared antigenic determinants of the various M proteins although protection of mice could not be measured as a function of circulating anti-M antibodies.

Full text

PDF
104

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergner-Rabinowitz S., Ofek I., Moody M. D. Cross-protection among serotypes of group A streptococci. J Infect Dis. 1972 Apr;125(4):339–344. doi: 10.1093/infdis/125.4.339. [DOI] [PubMed] [Google Scholar]
  2. FOX E. N. ANTIGENICITY OF THE M PROTEINS OF GROUP A HEMOLYTIC STREPTOCOCCI. J Immunol. 1964 Nov;93:826–837. [PubMed] [Google Scholar]
  3. Fox E. N. M proteins of group A streptococci. Bacteriol Rev. 1974 Mar;38(1):57–86. doi: 10.1128/br.38.1.57-86.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fox E. N., Waldman R. H., Wittner M. K., Mauceri A. A., Dorfman A. Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers. J Clin Invest. 1973 Aug;52(8):1885–1892. doi: 10.1172/JCI107372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fox E. N., Wittner M. K. Antigenicity of the M proteins of group A hemolytic streptococci. II. Antibody response in rabbits to vaccines prepared with oil emulsions and aluminum hydroxide. J Immunol. 1966 Jul;97(1):86–94. [PubMed] [Google Scholar]
  6. Fox E. N., Wittner M. K. Antigenicity of the M proteins of group A hemolytic streptococci. IV. Cross-reactivity between serotypes. J Immunol. 1968 Jan;100(1):39–45. [PubMed] [Google Scholar]
  7. Fox E. N., Wittner M. K., Dorfman A. Antigenicity of the M proteins of group A hemolytic streptococci. 3. Antibody responses and cutaneous hypersensitivity in humans. J Exp Med. 1966 Dec 1;124(6):1135–1151. doi: 10.1084/jem.124.6.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fox E. N., Wittner M. K. The multiple molecular structure of the M proteins of group A streptococci. Proc Natl Acad Sci U S A. 1965 Oct;54(4):1118–1125. doi: 10.1073/pnas.54.4.1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Harrell W. K., Ashworth H., Davis R. E., 2nd Cross-protective antigens of group A streptococci types 3 and 31 and types 46 and 51. Infect Immun. 1971 Jul;4(1):79–84. doi: 10.1128/iai.4.1.79-84.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. LANCEFIELD R. C. Current knowledge of type-specific M antigens of group A streptococci. J Immunol. 1962 Sep;89:307–313. [PubMed] [Google Scholar]
  11. LANCEFIELD R. C. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J Exp Med. 1957 Oct 1;106(4):525–544. doi: 10.1084/jem.106.4.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Michael J. G., Massell B. F. Dynamics in development of experimental streptococcal immunity in mice. J Bacteriol. 1968 Jul;96(1):131–138. doi: 10.1128/jb.96.1.131-138.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Polly S. M., Waldman R. H., High P., Wittner M. K., Dorfman A. Protective studies with a group A streptococcal M protein vaccine. II. Challange of volenteers after local immunization in the upper respiratory tract. J Infect Dis. 1975 Mar;131(3):217–224. doi: 10.1093/infdis/131.3.217. [DOI] [PubMed] [Google Scholar]
  14. Rotta J., Prendergast T. J., Karakawa W. W., Harmon C. K., Krause R. M. Enhanced resistance to streptococcal infection induced in mice by cell wall mucopeptide. J Exp Med. 1965 Nov 1;122(5):877–890. doi: 10.1084/jem.122.5.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. WILEY G. G., WILSON A. T. The occurrence of two M antigens in certain group A streptococci related to type 14. J Exp Med. 1961 Feb 1;113:451–465. doi: 10.1084/jem.113.2.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wiley G. G., Bruno P. N. Cross-reactions among Group A streptococci. I. Precipitin and bactericidal cross-reactions among types 33, 41, 43, 52, and Ross. J Exp Med. 1968 Nov 1;128(5):959–968. doi: 10.1084/jem.128.5.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wittner M. K. Antigenicity of the M proteins of group A hemolytic streptococci: further evidence for shared determinants among serotypes. Infect Immun. 1976 Feb;13(2):634–642. doi: 10.1128/iai.13.2.634-642.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES